Cash and Cash Equivalents, at Carrying Value of Innovation1 Biotech Inc. from 31 Aug 2017 to 29 Feb 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Innovation1 Biotech Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Aug 2017 to 29 Feb 2024.
  • Innovation1 Biotech Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 29 Feb 2024 was $107,527.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Innovation1 Biotech Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $107,527 29 Feb 2024 10-Q 06 May 2025 2024 Q2
Q4 2023 $5,819 30 Nov 2023 10-Q 27 Jan 2025 2023 Q1
Q3 2023 $49,849 -$106,637 -68% 31 Aug 2023 10-Q 06 May 2025 2024 Q2
Q3 2022 $156,486 +$19,010 +14% 31 Aug 2022 10-K 15 Dec 2022 2022 FY
Q2 2022 $636,159 +$604,957 +1939% 31 May 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 $1,310,285 +$1,284,991 +5080% 28 Feb 2022 10-Q 15 Apr 2022 2022 Q2
Q4 2021 $2,933,712 +$2,904,162 +9828% 30 Nov 2021 10-Q/A 01 Feb 2022 2022 Q1
Q3 2021 $137,476 +$119,595 +669% 31 Aug 2021 10-K 15 Dec 2022 2022 FY
Q2 2021 $31,202 -$2,537 -7.5% 31 May 2021 10-Q 14 Jul 2022 2022 Q3
Q1 2021 $25,294 -$17,992 -42% 28 Feb 2021 10-Q 15 Apr 2022 2022 Q2
Q4 2020 $29,550 -$11,896 -29% 30 Nov 2020 10-Q/A 01 Feb 2022 2022 Q1
Q3 2020 $17,881 -$1,094 -5.8% 31 Aug 2020 10-Q 14 Jul 2022 2022 Q3
Q2 2020 $33,739 +$19,804 +142% 31 May 2020 10-Q 13 Jul 2021 2021 Q3
Q1 2020 $43,286 29 Feb 2020 10-Q 14 Apr 2021 2021 Q2
Q4 2019 $41,446 30 Nov 2019 10-Q 13 Jan 2021 2021 Q1
Q3 2019 $18,975 -$755,493 -98% 31 Aug 2019 10-K 10 Dec 2021 2021 FY
Q2 2019 $13,935 +$6,442 +86% 31 May 2019 10-Q 20 Jul 2020 2020 Q3
Q3 2018 $774,468 +$774,443 31 Aug 2018 10-K 15 Dec 2020 2020 FY
Q2 2018 $7,493 31 May 2018 10-Q 18 Jul 2019 2019 Q3
Q3 2017 $25* 31 Aug 2017 10-K 17 Dec 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.